{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sickle-cell-disease/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"48757ec5-731a-57fd-8e39-d2cdf918179a","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field e8490844-35bc-4da7-bdba-0a1fd1fdf007 --><h2>Update</h2><!-- end field e8490844-35bc-4da7-bdba-0a1fd1fdf007 -->","summary":null,"htmlStringContent":"<!-- begin item 2ad42884-a7b3-4f3e-a9ba-f10cf3c263ca --><!-- end item 2ad42884-a7b3-4f3e-a9ba-f10cf3c263ca -->","topic":{"id":"eb346bd0-1df2-5db2-a583-a366e34cfc19","topicId":"cc107f5d-efe6-4625-840e-5c4d4656869b","topicName":"Sickle cell disease","slug":"sickle-cell-disease","lastRevised":"Last revised in November 2016","chapters":[{"id":"d2b6d668-4d29-5c50-b65d-7467cbcce2dd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"47f9af8d-8bda-55a3-bf81-eb75a7c4f02a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4a0ece3e-fa44-5ecd-9f55-ac17384d960c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"44a5b5f9-fc8e-5024-87e3-a7e42dca3dd9","slug":"changes","fullItemName":"Changes"},{"id":"48757ec5-731a-57fd-8e39-d2cdf918179a","slug":"update","fullItemName":"Update"}]},{"id":"53ae2089-f545-5b24-99c5-a9fc620ea575","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ffff20e4-5bc5-5c3b-bb59-858dba2fcf8d","slug":"goals","fullItemName":"Goals"},{"id":"16f85d1d-aec7-5173-9e0b-7d9456bdf3a5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12a41d5f-f447-5a64-868a-7648c7de9355","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5de2a0f3-a77d-5244-a401-dbd2cbcfefb3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fc893fb4-51ec-5705-8dff-c7fba1969646","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cc1cc5c4-df13-5e74-bde0-9f625ec4d1cf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"02e2bd4f-75cd-5b59-9a81-c06d3bcf4d2f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2a8eb5f7-6691-505b-bd86-9620102057a3","slug":"definition","fullItemName":"Definition"},{"id":"b756c83a-dcc0-5792-b3f9-fa9416929ce3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"488c0ab1-f1c0-5fbf-bd1e-e327181c2e1f","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b62a5aae-0dc3-5ac0-a1b1-d3ca0a7969ac","slug":"complications","fullItemName":"Complications"}]},{"id":"9336c0e7-d5d3-5dd6-99fd-50610ced96e1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dd5a2bec-36ce-58c0-b0f1-4ec5d4d17c21","slug":"when-to-suspect-sickle-cell-disease","fullItemName":"When to suspect sickle cell disease"},{"id":"bdbf4e2a-7a0c-5a2e-8b9c-4a9c661409ef","slug":"diagnosis-of-sickle-cell-disease","fullItemName":"Diagnosis of sickle cell disease"},{"id":"68746f0d-607a-5db5-8949-a87a4ed29328","slug":"when-to-suspect-an-acute-sickle-cell-crisis","fullItemName":"When to suspect an acute sickle cell crisis"},{"id":"ed48dbda-a404-50cf-a290-86fafcdb9908","slug":"assessment-of-acute-crisis","fullItemName":"Assessment of acute crisis"}]},{"id":"221fb88b-b951-5835-b282-ed218b637ff0","fullItemName":"Management","slug":"management","subChapters":[{"id":"e76854fe-5d45-5d85-8591-5712daa7e4d9","slug":"screening","fullItemName":"Scenario: Screening"},{"id":"1da4d393-99a4-51c1-b354-f1742b9d8b1f","slug":"management-sickle-cell-crisis","fullItemName":"Scenario: Management - sickle cell crisis"},{"id":"2bf8553c-1641-5bdc-bbc3-2615ddc5b84c","slug":"management-chronic-complications","fullItemName":"Scenario: Management - chronic complications"},{"id":"4493185d-8907-5325-a195-a7cd7039bd68","slug":"prevention-of-complications","fullItemName":"Scenario: Prevention of complications"},{"id":"2aeac855-0e31-598c-804d-41c8d9bc643f","slug":"management-sickle-cell-trait","fullItemName":"Scenario: Management - sickle cell trait"},{"id":"5b85ac92-9286-564f-88fb-ec37a6f4102e","slug":"contraception","fullItemName":"Scenario: Contraception"}]},{"id":"a424bf70-c56c-54a4-a2e2-019ab7c27c69","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"515607d5-c2e2-5a4c-8d83-1bb5e320badf","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2148be5b-6502-5e45-b86b-e552aa3226fd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"acc3b704-7f3d-51ed-869e-38e0309c53e5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2a46384b-d43c-536a-9a17-4b8953d8457a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"46873f42-ab32-5894-b2fe-429a4e62161b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1dd24310-b8ac-5381-b51a-ca1f6c178d72","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7405fe0a-8432-5e64-9fe0-4d112fd89232","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4a0ece3e-fa44-5ecd-9f55-ac17384d960c","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"8c94fb25-07bd-55bc-8fe3-f41b2fcd1f20","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 85a78be6-1f9b-49c8-b1f6-3cabb3ab6567 --><h3>New evidence</h3><!-- end field 85a78be6-1f9b-49c8-b1f6-3cabb3ab6567 -->","summary":null,"htmlStringContent":"<!-- begin item 34a1c650-c486-4ae4-b360-063cf4f4fab7 --><!-- begin field 7e50674b-cc79-4cd4-b42d-9b865a3282f2 --><h3>Evidence-based guidelines</h3><!-- end field 7e50674b-cc79-4cd4-b42d-9b865a3282f2 --><!-- begin field 4eb898fc-325d-49f5-a3b9-cba906a4521c --><ul><li>BJH (2018) <em>Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease.</em> British Society of Haematology.</li></ul><!-- end field 4eb898fc-325d-49f5-a3b9-cba906a4521c --><!-- begin field 9f4d6963-9375-4a1f-beb4-58079fa85b68 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 9f4d6963-9375-4a1f-beb4-58079fa85b68 --><!-- begin field 8c565bce-9bc7-4254-bfbb-c26254e9190a --><p>No new HTAs since 1 November 2016.</p><!-- end field 8c565bce-9bc7-4254-bfbb-c26254e9190a --><!-- begin field 879ef2b0-77d4-4c45-9dab-54d653379d97 --><h3>Economic appraisals</h3><!-- end field 879ef2b0-77d4-4c45-9dab-54d653379d97 --><!-- begin field 917b2e90-6be2-4bf1-a32e-73696c88ae46 --><p>No new economic appraisals relevant to England since 1 November 2016.</p><!-- end field 917b2e90-6be2-4bf1-a32e-73696c88ae46 --><!-- begin field a817b818-527f-426b-bb28-9071c71050ca --><h3>Systematic reviews and meta-analyses</h3><!-- end field a817b818-527f-426b-bb28-9071c71050ca --><!-- begin field f6535430-639f-4108-94b8-1cb0155241c2 --><p>No new systematic reviews relevant to England since 1 November 2016.</p><!-- end field f6535430-639f-4108-94b8-1cb0155241c2 --><!-- begin field 2f6235cc-750e-4020-856e-9d0b64c4cb35 --><h3>Primary evidence</h3><!-- end field 2f6235cc-750e-4020-856e-9d0b64c4cb35 --><!-- begin field 81e120b5-4503-4174-9110-e5ec0e46dfd5 --><p>No new randomized controlled trials published since 1 November 2016.</p><!-- end field 81e120b5-4503-4174-9110-e5ec0e46dfd5 --><!-- end item 34a1c650-c486-4ae4-b360-063cf4f4fab7 -->","subChapters":[]},{"id":"ef25f7e3-bba0-536a-8f7d-71d74141ad7a","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field beb649a1-47a1-4f58-9176-7a9f7d561158 --><h3>New policies</h3><!-- end field beb649a1-47a1-4f58-9176-7a9f7d561158 -->","summary":null,"htmlStringContent":"<!-- begin item 1581f95f-64f2-4443-99f5-8ca8268e6ce5 --><!-- begin field 8ca9a5e5-d554-4938-88f5-5c1ad4bda86e --><p>No new national policies or guidelines since 1 November 2016.</p><!-- end field 8ca9a5e5-d554-4938-88f5-5c1ad4bda86e --><!-- end item 1581f95f-64f2-4443-99f5-8ca8268e6ce5 -->","subChapters":[]},{"id":"bd73b168-43ee-5728-863b-aa5c980a4b72","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field e5e9aa29-2f93-4054-b6df-888c86ea7525 --><h3>New safety alerts</h3><!-- end field e5e9aa29-2f93-4054-b6df-888c86ea7525 -->","summary":null,"htmlStringContent":"<!-- begin item 97516875-160c-4de7-ac29-7a273335aa90 --><!-- begin field 7656f924-294e-414e-a652-a87876062993 --><p>No new safety alerts since 1 November 2016.</p><!-- end field 7656f924-294e-414e-a652-a87876062993 --><!-- end item 97516875-160c-4de7-ac29-7a273335aa90 -->","subChapters":[]},{"id":"c1827da6-8013-5b43-9d1f-b1303065e7f4","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 62dfc8bd-1dfd-49a9-92fb-573f2651f882 --><h3>Changes in product availability</h3><!-- end field 62dfc8bd-1dfd-49a9-92fb-573f2651f882 -->","summary":null,"htmlStringContent":"<!-- begin item df8d1f28-ace1-47fd-b2ba-790d02416835 --><!-- begin field 48b029d6-749c-43e8-9fc4-64b30553266c --><p>No changes in product availability since 1 November 2016.</p><!-- end field 48b029d6-749c-43e8-9fc4-64b30553266c --><!-- end item df8d1f28-ace1-47fd-b2ba-790d02416835 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}